A randomized, open-label non-inferiority study to compare palonosetron and ondansetron for prevention of acute chemotherapy-induced vomiting in children with cancer receiving moderate or high emetogenic chemotherapy.

Sandeep JainKapoor GauriSahitya KoneruGayatri Vishwakarma

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2018)

Palonosetron is non-inferior and cost-effective compared to ondansetron for prevention of acute chemotherapy-induced vomiting (CIV) in children receiving moderate and high emetogenic chemotherapy.

Keyphrases

chemotherapy induced
liver failure
open label
respiratory failure
young adults
high intensity
drug induced
aortic dissection
papillary thyroid
clinical trial
randomized controlled trial
phase ii
study protocol
extracorporeal membrane oxygenation
mechanical ventilation
lymph node metastasis